Dr. David Abramson, MD

Dr. David Abramson, MD

Ophthalmology | Male | 72 years old

Learn about this doctor

Care Philosophy

I am an ophthalmic oncologist and the first Chief of the Ophthalmic Oncology Service at Memorial Sloan-Kettering Cancer Center. Ophthalmic oncologists are ophthalmologists who specialize in the diagnosis and treatment of cancer on the surface of the eye, in the eye, and in the tissues around the eye (lids, orbit). My appointment is a joint one in Surgery, Pediatrics, and Radiation Oncology. I perform all the surgery on ophthalmic oncology patients at MSK but in every case work closely with my colleagues in Pediatrics, Radiation Oncology, and Medicine. We are the only service dedicated to ophthalmic oncology in a cancer hospital in the US; and, because of our close association with these other services, we are able to offer coordinated, state-of-the-art care with access to novel therapies and clinical trials not available anywhere else in the country. After completing a residency in ophthalmology and a full year of research involving ultrasound and cancer of the eye, I did a fellowship in ophthalmic oncology and also spent additional time training at the Armed Forces Institute of Pathology in Washington, DC. I have had extensive experience in the diagnosis and treatment of cancers in and around the eye. Cancers in and around the eye are usually diagnosed without biopsy; and since all cancers in my area are rare, experience is very important in arriving at the correct diagnosis every time. To assist me, we have the latest in diagnostic digital imaging and ultrasound, including standardized A and B scan in addition to high frequency anterior segment ultrasound ('ultrasonic biomicroscopy,' or UBM). I have published more than 400 books, chapters, original articles, scientific reviews, audiotapes, and videotapes, and I was the editor of the American Academy's instruction book on Ophthalmic Oncology. I have delivered more than 400 lectures worldwide, including in France, Italy, Switzerland, Israel, China, Hong Kong, Canada, Mexico, Venezuela, Peru, Brazil, and Argentina. The most common cancer we see is melanoma in the eye. We offer every modern diagnostic and therapeutic option for these cancers, including brachytherapy ('plaques') with radioactive iodine and ruthenium. I work closely with our radiation oncologists, and our physicists and brachytherapy team are internationally respected for their expertise. Every plaque therapy is individually designed for each patient. I was a principal investigator (and author) of the 20-year NIH-sponsored trial called the COMS (Collaborative Ocular Melanoma Study), in which we demonstrated the most effective management of patients with ocular melanomas. I have been described as 'the Dean of Retinoblastoma,' and our retinoblastoma center is the longest continually operating retinoblastoma center in the world, with the longest follow-up of the largest number of patients ever. We have a newly constructed examination suite dedicated to the examinations of children with retinoblastoma, and in it is every modern piece of equipment that exists to diagnose and treat retinoblastoma. I have introduced many new treatments for retinoblastoma that have been adopted by other centers worldwide. These include the novel use of chemotherapy delivered around the eye to prevent systemic toxicity of intravenous medication. Our studies on the long-term complications of cancer diathesis in this disease have been published extensively in JAMA as well as ophthalmic and oncology journals. I have received awards from the Swiss Ophthalmological Society (for my work in childhood eye cancer and genetics), The Association for Research in Vision (for my contributions to clinical ophthalmological research), the Helen Keller Society (for my work with blind and limited-sighted children), and the New York State Ophthalmological Society (for my humanitarian approach to patients). I have received many teaching awards, and I have received the Honor Award and the Senior Honor Award from the American Academy of Ophthalmology.Read more

Dr. Abramson's Experience

0ExperienceMatch
Experience Match

See how Dr. Abramson's experience matches your preferences.

1
Specialties

For the best healthcare for your needs, choose a doctor who specializes in your medical condition.

1
Board Certifications

Board certification indicates that a doctor is highly qualified in the medical field in which they practice.

60
Conditions Treated

Check to see that this provider treats your medical condition.

11
Procedures Performed

Check to see that this provider performs the procedure that you need.

Background Check

Check to see if your provider has any malpractices, board actions, or sanctions.

Education

Learn more about where this provider went to medical school, residency, and more.

Awards & Recognition

View information about special awards and recognition for this provider.

Languages Spoken

Check to see what languages this provider and/or staff speak.

Memberships & Professional Affiliations

View memberships and affiliations associated with this provider.

Visiting Dr. Abramson

Dr. Abramson accepts 25 insurance carriers

Affiliated Hospitals

Hospital Quality

Check out the quality of care at the 1 hospitals where Dr. Abramson has admitting privileges.

Hospital Quality Awards

×

Dr. Abramson's Reviews

Likelihood of recommending Dr. Abramson to family and friends
5
based on 8 total surveys
Key Survey Insights
  • Trustworthiness
     (8)
  • Helpfulness
     (8)
  • Staff
     (8)
  • Scheduling
     (8)
Experience with Dr. Abramson
  • Level of trust in provider's decisions
     (8)
  • How well provider explains medical condition(s)
     (8)
  • How well provider listens and answers questions
     (8)
  • Spends appropriate amount of time with patients
     (8)
Dr. Abramson's Office & Staff
  • Ease of scheduling urgent appointments
     (8)
  • Office environment, cleanliness, comfort, etc.
     (8)
  • Staff friendliness and courteousness
     (8)
  • Total wait time (waiting & exam rooms)
    10 – 15 minutes (7)
Have you seen Dr. David Abramson, MD?
Are you Dr. Abramson?
Make it easy for patients to share their feedback. Also manage your personalized profile!
Get started today!

Compare Dr. Abramson

Compare this Doctor
View other doctors with similar experience to find the right doctor for you.
View all 10 matches

Dr. Abramson's Care Philosophy

I am an ophthalmic oncologist and the first Chief of the Ophthalmic Oncology Service at Memorial Sloan-Kettering Cancer Center. Ophthalmic oncologists are ophthalmologists who specialize in the diagnosis and treatment of cancer on the surface of the eye, in the eye, and in the tissues around the eye (lids, orbit). My appointment is a joint one in Surgery, Pediatrics, and Radiation Oncology. I perform all the surgery on ophthalmic oncology patients at MSK but in every case work closely with my colleagues in Pediatrics, Radiation Oncology, and Medicine. We are the only service dedicated to ophthalmic oncology in a cancer hospital in the US; and, because of our close association with these other services, we are able to offer coordinated, state-of-the-art care with access to novel therapies and clinical trials not available anywhere else in the country.

After completing a residency in ophthalmology and a full year of research involving ultrasound and cancer of the eye, I did a fellowship in ophthalmic oncology and also spent additional time training at the Armed Forces Institute of Pathology in Washington, DC.

I have had extensive experience in the diagnosis and treatment of cancers in and around the eye. Cancers in and around the eye are usually diagnosed without biopsy; and since all cancers in my area are rare, experience is very important in arriving at the correct diagnosis every time. To assist me, we have the latest in diagnostic digital imaging and ultrasound, including standardized A and B scan in addition to high frequency anterior segment ultrasound ('ultrasonic biomicroscopy,' or UBM).

I have published more than 400 books, chapters, original articles, scientific reviews, audiotapes, and videotapes, and I was the editor of the American Academy's instruction book on Ophthalmic Oncology. I have delivered more than 400 lectures worldwide, including in France, Italy, Switzerland, Israel, China, Hong Kong, Canada, Mexico, Venezuela, Peru, Brazil, and Argentina.

The most common cancer we see is melanoma in the eye. We offer every modern diagnostic and therapeutic option for these cancers, including brachytherapy ('plaques') with radioactive iodine and ruthenium. I work closely with our radiation oncologists, and our physicists and brachytherapy team are internationally respected for their expertise. Every plaque therapy is individually designed for each patient. I was a principal investigator (and author) of the 20-year NIH-sponsored trial called the COMS (Collaborative Ocular Melanoma Study), in which we demonstrated the most effective management of patients with ocular melanomas.

I have been described as 'the Dean of Retinoblastoma,' and our retinoblastoma center is the longest continually operating retinoblastoma center in the world, with the longest follow-up of the largest number of patients ever. We have a newly constructed examination suite dedicated to the examinations of children with retinoblastoma, and in it is every modern piece of equipment that exists to diagnose and treat retinoblastoma. I have introduced many new treatments for retinoblastoma that have been adopted by other centers worldwide. These include the novel use of chemotherapy delivered around the eye to prevent systemic toxicity of intravenous medication. Our studies on the long-term complications of cancer diathesis in this disease have been published extensively in JAMA as well as ophthalmic and oncology journals.

I have received awards from the Swiss Ophthalmological Society (for my work in childhood eye cancer and genetics), The Association for Research in Vision (for my contributions to clinical ophthalmological research), the Helen Keller Society (for my work with blind and limited-sighted children), and the New York State Ophthalmological Society (for my humanitarian approach to patients). I have received many teaching awards, and I have received the Honor Award and the Senior Honor Award from the American Academy of Ophthalmology.

Dr. Abramson's experience matches your search based on the following criteria:

  •  Based on total number of patients treated over the last 12 months
  •  Specializes in Ophthalmology
  •  Board certified in Ophthalmology
  •  No malpractice claims found
  •  No sanctions found
  •  No board actions found

Awards & Recognition

  • Awards & Honors
    • Healthgrades Honor Roll
    What is a recognized doctor
  • Media & Publications

    Dr. Abramson has no media or publications listed.

Background Check

  • 0
    Malpractice Claims

    No malpractice history found for New York.

    What is medical malpractice
  • 0
    Sanctions

    No sanctions history found for the years that Healthgrades collects data.

    What is a sanction or disciplinary action
  • 0
    Board Actions

    No board actions found for the years that Healthgrades collects data.

    What are board actions

Background Check

Why It Matters: Dr. Abramson's Board Certifications

Board certification should be one of your top considerations when choosing a doctor. Board certification is an official recognition given to doctors who have met specific requirements set by national medical specialty boards in the... More

  • Ophthalmology

Conditions Treated

  • Age-Related Macular Degeneration
  • All Headaches (incl. Migraine)
  • Aphakia and Other Disorders of Lens
  • Autoimmune Diseases
  • Bell's Palsy
  • Benign Neoplasm of Choroid
  • Benign Neoplasm of Eye
  • Benign Tumor
  • Blepharitis
  • Blind Hypotensive Eye
  • Blindness
  • Brain Disorders
  • Cancer
  • Cataract
  • Chalazion
  • Chorioretinal Scars
  • Chorioretinitis
  • Conjunctival Hemorrhage
  • Dacryoadenitis
  • Drooping Eyelids (Ptosis)
  • Drusen
  • Dry Eyes
  • Endophthalmitis
  • Esotropia
  • Exotropia
  • Eye Cancer
  • Eye Infections
  • Eye Melanoma
  • Eyelid Disorders
  • Floaters
  • Focal Chorioretinitis and Focal Retinochoroiditis
  • Glaucoma
  • Headache
  • Hyphema
  • Iridocyclitis
  • Keratitis
  • Leucocoria
  • Macular Hole
  • Malignant Neoplasm of Eye
  • Migraine
  • Nearsightedness
  • Nerve Sheath Tumors
  • Nystagmus
  • Optic Neuritis
  • Orbital Cellulitis
  • Pinkeye (Conjunctivitis)
  • Purulent Endophthalmitis
  • Retina Diseases
  • Retinal Detachment and Retinal Tear
  • Retinal Hemorrhage
  • Retinal Telangiectasia
  • Retinoblastoma
  • Retinopathy of Prematurity (ROP)
  • Retinoschisis
  • Senile Cataracts
  • Thyroid Disease
  • Ulcer
  • Uveitis and Iridocyclitis
  • Vascular Disease
  • Vitreous Hemorrhage

Education

  • Medical School
    Albert Einstein College Of Medicine Of Yeshiva University
  • Internship Hospital
    Einstein Coll Med

    Completed in 1970

  • Residency Hospital
    Albert Einstein College Of Medicine/Lincoln Hospital
    Columbia-Presbyterian Medical Center
  • Fellowship Hospital
    Columbia-Presbyterian Medical Center

Languages Spoken

  • English

Memberships &
Professional Affiliations

Dr. Abramson does not have any memberships or affiliations listed. If you are Dr. Abramson and would like to add memberships or affiliations, please update your free profile.

Specialties

  • Ophthalmology

Procedures Performed

  • Blepharorrhaphy
  • Destruction of Lesion of Retina and Choroid
  • Enucleation of Eye
  • Excision or Destruction of Lesion of Cornea
  • Extraocular Muscle Surgery
  • Eye Surgery
  • Eyelid Surgery
  • Ocular Prosthetics
  • Orbital Decompression and Orbitotomy
  • Repair of Retinal Detachment or Retinal Tear
  • Vitreoretinal Surgery

You've got options

We're finding other great Providers for you to consider.